2017/02/02 - Quantum Genomics granted key European patent for QGC011 combination therapy program

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the issuance of a key new patent by the European Patent Office.